UNC Lineberger News

Researchers license new technology

GeneCentric now has two separate exclusive licenses to diagnostic technologies from the University of North Carolina at Chapel Hill. The company was co-founded in 2011 by UNC Lineberger researchers Drs. Charles Perou and Neil Hayes, who discovered molecular signatures critical in distinguishing clinically relevant subtypes of lung cancer.

Researchers license new technology - Read More…

Carolina cracks top 10 in federal R&D expenditures

UNC-Chapel Hill rose to ninth from 16th among leading private and public research universities for the level of federal funding ($545.99 million) devoted to research and development in all fields during fiscal 2010.

Carolina cracks top 10 in federal R&D expenditures - Read More…

UNC headlines American Cancer Society breakfast

UNC headlines American Cancer Society breakfast

UNC Head Basketball Coach Roy Williams and UNC Lineberger physician-scientist Kim Rathmell, MD, PhD, were featured speakers at the American Cancer Society’s Cancer Action Network breakfast, held August 24th in Research Triangle Park.

UNC headlines American Cancer Society breakfast - Read More…

Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services

Kayaking and rock climbing aren’t usual clinical activities for UNC Lineberger medical oncologist Dr. Juneko Grilley-Olson and nurse practitioner Elizabeth Sherwood, but they were during the time that each volunteered for a First Descents camp week for young adult cancer survivors.

Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services - Read More…

Study reveals new molecular target for melanoma treatment

Study reveals new molecular target for melanoma treatment

Chapel Hill, NC – A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.

Study reveals new molecular target for melanoma treatment - Read More…

The V Foundation selects UNC team as 2012 translational grant recipients

The V Foundation selects UNC team as 2012 translational grant recipients

The V Foundation for Cancer Research, one of the nation’s leading cancer research foundations, has awarded a $600,000 grant to a UNC Lineberger team.

The V Foundation selects UNC team as 2012 translational grant recipients - Read More…

B Cell survival holds key to chronic graft vs. host disease

B Cell survival holds key to chronic graft vs. host disease

Chapel Hill, NC – Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival.

B Cell survival holds key to chronic graft vs. host disease - Read More…

Kathy DeClue: a selfless gift from a younger brother

A Randolph County woman with leukemia receives stem cells from her youngest brother in hopes of restoring her health and returning to work as a baker.

Kathy DeClue: a selfless gift from a younger brother - Read More…

Making the case for adjuvant chemotherapy for older patients with colon cancer

Making the case for adjuvant chemotherapy for older patients with colon cancer

Hy Muss, MD, and Debra Bynum, MD, co-authored an editorial in the July 20, 2012 issue of the Journal of Clinical Oncology.

Making the case for adjuvant chemotherapy for older patients with colon cancer - Read More…

UNC team describes novel inflammatory protein function

UNC team describes novel inflammatory protein function

A UNC-led team of scientists describes the function of a previously uncharacterized protein that dramatically influences inflammation.

UNC team describes novel inflammatory protein function - Read More…

UNC Lineberger announces first Marci Kramish Campbell Dissertation Award recipient

UNC Lineberger announces first Marci Kramish Campbell Dissertation Award recipient

Chapel Hill, NC – Carmina G. Valle, MPH, is the recipient of the first Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences.

UNC Lineberger announces first Marci Kramish Campbell Dissertation Award recipient - Read More…

DeSimone gives podcast interview to EarthSky

Joseph DeSimone, PhD, Chancellor's Eminent Professor of Chemistry, gave an interview to EarthSky regarding his green inventions, his current work and the future of science.

DeSimone gives podcast interview to EarthSky - Read More…

McCrory earns medal at Olympic games

Nick McCrory, the son of Ana and Doug McCrory, won a bronze medal in the Olympic men’s 10-meter synchronized diving competition with partner David Boudia. Nick’s mother, Ana, works in the UNC Lineberger Tissue Culture Facility.

McCrory earns medal at Olympic games - Read More…

Evans discusses company's request for FDA approval of personalized DNA test

Evans discusses company's request for FDA approval of personalized DNA test

James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in an article on NPR's website discussing a recent request by a genetic test maker for the Food and Drug Administration to approve its personalized DNA test.

Evans discusses company's request for FDA approval of personalized DNA test - Read More…

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor

Life is full of choices, and even cells come to a fork in the road. They have to decide what to do about damage to their DNA: repair the damage, force the damaged cell to die, or allow the damage to transform the cell to a tumor cell.

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor - Read More…

UNC graduate students awarded Howard Hughes Medical Institute Fellowships

Three UNC graduate students were awarded International Predoctoral Fellowships by the Howard Hughes Medical Institute. Onur Dagliyan, Alakananda Das, and Mira Pronobis each received a $43,000 fellowship.

UNC graduate students awarded Howard Hughes Medical Institute Fellowships - Read More…

UNC Lineberger scientists receive grant for pulmonary inflammation research

UNC Lineberger scientists receive grant for pulmonary inflammation research

Three UNC Lineberger researchers are collaborating on a project recently awarded more than $3.3 million over five years from the National Institutes of Health’s National Heart, Lung, and Blood Institute.

UNC Lineberger scientists receive grant for pulmonary inflammation research - Read More…

Human papillomavirus types do not replace others after large-scale vaccination

Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18. Is there a chance that the increased number of people vaccinated might result in an increase of other types of HPV that cause cancer?

Human papillomavirus types do not replace others after large-scale vaccination - Read More…

Diving into the Summer Olympics, UNC Lineberger employee's special connection

Diving into the Summer Olympics, UNC Lineberger employee's special connection

Ana McCrory of the Tissue Culture Facility will be making a special trip to London in July. She, her husband, Doug, their son, Lucas, and other family members are traveling to cheer on her son, Nick, who is a member of the 11-member US diving team for the 2012 Summer Olympics.

Diving into the Summer Olympics, UNC Lineberger employee's special connection - Read More…

Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section

Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section

Dirk Dittmer, PhD, professor of microbiology and immunology, has been selected to serve as chair of the AIDS-Associated Opportunistic Infections and Cancer Study Section, for the Center for Scientific Review, a program of the National Institutes of Health.

Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section - Read More…

“Corona Cares” supports patients, families dealing with cancer

RALEIGH, NC – Crown Imports announced today that the highly successful “Corona Cares” charitable donation program in North Carolina will kick off on August 1 to benefit patient and family support programs at the N.C. Cancer Hospital. Over the past two years, “Corona Cares” has provided more than $210,000 for these programs.

“Corona Cares” supports patients, families dealing with cancer - Read More…

Study shows colon and rectal tumors constitute a single type of cancer

The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment.

Study shows colon and rectal tumors constitute a single type of cancer - Read More…

Kenan Institute appoints Joseph DeSimone as new director

Kenan Institute appoints Joseph DeSimone as new director

The University of North Carolina at Chapel Hill’s Frank Hawkins Kenan Institute of Private Enterprise has appointed Joseph M. DeSimone as its new director.

Kenan Institute appoints Joseph DeSimone as new director - Read More…

Cancer one of three UNC specialties nationally ranked by U.S. News

Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.

Cancer one of three UNC specialties nationally ranked by U.S. News - Read More…

Pox, patents and pancreatic cancer vaccines

Pox, patents and pancreatic cancer vaccines

Rachel Roper, PhD, Associate Professor of Microbiology & Immunology at East Carolina’s Brody School of Medicine has been granted a patent for her discovery of a poxvirus gene that, when deleted, significantly weakens the vaccine virus while simultaneously increasing immune responses to it.

Pox, patents and pancreatic cancer vaccines - Read More…

Amos quoted in ABC News feature

Amos quoted in ABC News feature

Keith Amos, MD, assistant professor of surgery at UNC-Chapel Hill, is quoted in an ABC News feature discussing a new study about partial breast removal surgery to treat cancer.

Amos quoted in ABC News feature - Read More…

Strader honored by Leukemia & Lymphoma Society

Strader honored by Leukemia & Lymphoma Society

John Strader, PA-C with the hematologic malignancies program, was honored as the 2012 Man of the Year by the Leukemia & Lymphoma Society, North Carolina chapter, raising over $30,000 for the organization.

Strader honored by Leukemia & Lymphoma Society - Read More…

Preclinical studies use specialized ultrasound to detect presence of cancer

Preclinical studies use specialized ultrasound to detect presence of cancer

Chapel Hill - From the air, the twists and turns of rivers can easily be seen. In the body, however, tracing the twists and turns of blood vessels is difficult, but important. Vessel “bendiness” can indicate the presence and progression of cancer.

Preclinical studies use specialized ultrasound to detect presence of cancer - Read More…

Key biomarker’s new role in head and neck cancer

Key biomarker’s new role in head and neck cancer

Researchers at UNC have proposed a novel interpretation of an old biomarker which, if validated, could fundamentally transform the management of head and neck cancer.

Key biomarker’s new role in head and neck cancer - Read More…

Antibodies reverse Type 1 diabetes in new immunotherapy study

Antibodies reverse Type 1 diabetes in new immunotherapy study

CHAPEL HILL, NC – Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections maintained disease remission indefinitely without harming the immune system.

Antibodies reverse Type 1 diabetes in new immunotherapy study - Read More…

Advocates join together to raise awareness about pancreatic cancer

Advocates join together to raise awareness about pancreatic cancer

When scientists and advocates join forces, good things can happen. Dr. Channing Der, Sarah Graham Kenan Professor of Pharmacology and UNC Lineberger faculty member, and Lori Matteson, a Raleigh pancreatic cancer survivor and advocate, joined over 600 other pancreatic cancer advocates and family members on a visit to Washington, DC.

Advocates join together to raise awareness about pancreatic cancer - Read More…

Stitzenberg appointed to term on NC advisory committee

Stitzenberg appointed to term on NC advisory committee

Karyn Stitzenberg, MD, MPH, has been appointed to a four-year term on the North Carolina Advisory Committee on Cancer Coordination and Control.

Stitzenberg appointed to term on NC advisory committee - Read More…

Junk-food diets spur inflammation more than saturated fats alone

Junk-food diets spur inflammation more than saturated fats alone

A diet based on American junk food could lead to more obesity-induced inflammation than a diet high in animal fat, according to a new study by researchers at the University of North Carolina at Chapel Hill.

Junk-food diets spur inflammation more than saturated fats alone - Read More…

Bruce Ham shares his story, how support group for single fathers due to cancer helps him

Bruce Ham heard about the “Support Program for Single Fathers” from a friend. “I attended the first meeting. The guys in the group were going through exactly what I was going through and they were a similar age, they had all lost their wives to cancer, they all had kids in the house, so we had a lot in common. That’s what made it appealing to me.”

Bruce Ham shares his story, how support group for single fathers due to cancer helps him - Read More…

UNC Lineberger honors five clinical fellows

UNC Lineberger honors five clinical fellows

UNC Lineberger honored five clinical fellows for their research accomplishments and clinical excellence.

UNC Lineberger honors five clinical fellows - Read More…

New JAMA study shows stepped-care intervention results in weight loss at lower cost, UNC's Deborah Tate co-author

New JAMA study shows stepped-care intervention results in weight loss at lower cost, UNC's Deborah Tate co-author

A customized weight loss program may cost less to implement – despite having similar results – than a traditional weight loss program, according to a study published in the June 27 issue of The Journal of the American Medical Association (JAMA).

New JAMA study shows stepped-care intervention results in weight loss at lower cost, UNC's Deborah Tate co-author - Read More…

Making genomes make sense

CHAPEL HILL, NC – Sometimes, technology progresses faster than our ability to take advantage of it.

Making genomes make sense - Read More…

RN: Real Nurses - Barbara Riff

RN: Real Nurses - Barbara Riff

Parking difficulties inspired Barbara Riff to take motorcycle lessons with her son. Now she commutes to work via motorcycle and frequently takes motorcycle trips for fun.

RN: Real Nurses - Barbara Riff - Read More…

Exercise, even mild physical activity, may reduce breast cancer risk

Exercise, even mild physical activity, may reduce breast cancer risk

A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity - either mild or intense and before or after menopause - may reduce breast cancer risk, but substantial weight gain may negate these benefits.

Exercise, even mild physical activity, may reduce breast cancer risk - Read More…

Transplant survivors face chronic financial stressors

Transplant survivors face chronic financial stressors

Following a blood stem cell transplant, survivors can face serious economic challenges that may negatively affect their quality of life.

Transplant survivors face chronic financial stressors - Read More…

Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer

Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer

Lisa Carey, MD, authored an editorial, titled “Neoadjuvant Trials of Human Epidermal Growth Factor Receptor 2 Targeting: How Many Drugs Do We Need?”

Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer - Read More…